Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Lite Strategy, Inc. LITS NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
50/100
1/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Analyst Consensus — LITS

No analyst consensus data available for LITS.

People Also View

RLMD
RLMD
Relmada Therapeutics, Inc.
$7.18
-0.14%
 IMUX
IMUX
Immunic, Inc.
$1.11
-5.93%
 ACET
ACET
Adicet Bio, Inc.
$7.92
+13.14%
 PMVP
PMVP
PMV Pharmaceuticals, Inc.
$1.41
-4.08%
 XBIT
XBIT
XBiotech Inc.
$2.46
+1.23%
 TCRX
TCRX
TScan Therapeutics, Inc.
$1.07
+0.94%
 ACRV
ACRV
Acrivon Therapeutics, Inc. Common Stock
$1.67
+1.83%
 NTRB
NTRB
Nutriband Inc.
$4.08
+0.49%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message